These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16627626)
1. Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. Zhang J; Liu Q; Chen Q; Liu NQ; Li FL; Lu ZB; Qin C; Zhu H; Huang YY; He W; Zhao BL FASEB J; 2006 Jun; 20(8):1212-4. PubMed ID: 16627626 [TBL] [Abstract][Full Text] [Related]
2. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Zhang J; Mori A; Chen Q; Zhao B Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711 [TBL] [Abstract][Full Text] [Related]
3. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind). Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877 [TBL] [Abstract][Full Text] [Related]
4. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638 [TBL] [Abstract][Full Text] [Related]
5. Metals and amyloid-beta in Alzheimer's disease. Maynard CJ; Bush AI; Masters CL; Cappai R; Li QX Int J Exp Pathol; 2005 Jun; 86(3):147-59. PubMed ID: 15910549 [TBL] [Abstract][Full Text] [Related]
6. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease. Dingwall C Biochem Soc Trans; 2007 Jun; 35(Pt 3):571-3. PubMed ID: 17511654 [TBL] [Abstract][Full Text] [Related]
7. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276 [TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro. Mousavi M; Hellström-Lindahl E Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588 [TBL] [Abstract][Full Text] [Related]
9. Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil. James SA; Churches QI; de Jonge MD; Birchall IE; Streltsov V; McColl G; Adlard PA; Hare DJ ACS Chem Neurosci; 2017 Mar; 8(3):629-637. PubMed ID: 27958708 [TBL] [Abstract][Full Text] [Related]
11. Role of copper and the copper-related protein CUTA in mediating APP processing and Aβ generation. Hou P; Liu G; Zhao Y; Shi Z; Zheng Q; Bu G; Xu H; Zhang YW Neurobiol Aging; 2015 Mar; 36(3):1310-5. PubMed ID: 25557959 [TBL] [Abstract][Full Text] [Related]
12. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity. Hashimoto Y; Matsuoka M J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423 [TBL] [Abstract][Full Text] [Related]
13. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease. Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540 [TBL] [Abstract][Full Text] [Related]
14. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. Schäfer S; Pajonk FG; Multhaup G; Bayer TA J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610 [TBL] [Abstract][Full Text] [Related]
15. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077 [TBL] [Abstract][Full Text] [Related]
16. The amyloid paradox: amyloid-beta-metal complexes can be neurotoxic and neuroprotective. Bishop GM; Robinson SR Brain Pathol; 2004 Oct; 14(4):448-52. PubMed ID: 15605992 [TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Nordberg A; Hellström-Lindahl E; Lee M; Johnson M; Mousavi M; Hall R; Perry E; Bednar I; Court J J Neurochem; 2002 May; 81(3):655-8. PubMed ID: 12065674 [TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
19. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity. Seo J; Kim S; Kim H; Park CH; Jeong S; Lee J; Choi SH; Chang K; Rah J; Koo J; Kim E; Suh Y Biol Psychiatry; 2001 Feb; 49(3):240-7. PubMed ID: 11230875 [TBL] [Abstract][Full Text] [Related]
20. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]